Running Out of Medicine: — What to Do About Refills and Shortages

There is no single answer that applies to all cancer medicines. Some allow brief interruptions your team can manage; others have schedules where consistency is critical. This is a question to put directly to your oncologist with the specific medicine name — they can tell you how urgent the situation is and what your window looks like. Do not estimate this yourself based on what you read online, because the answer is specific to your drug and regimen.

Sometimes, but not always, and never without checking with your team first. Generic versions of the same molecule are often equivalent, but formulation differences — whether a tablet is extended-release or immediate-release, for example — can matter significantly for some cancer medicines. Your oncologist or clinical pharmacist can tell you whether a specific alternative is safe for you. That call takes less than a minute and removes the guesswork.

Tell your oncology team immediately, and give them the pharmacy's name and the medicine name. They may know of other suppliers, have access to a hospital pharmacy that stocks it, or be able to liaise with the manufacturer. In some situations, a short course from a different centre or city can bridge the gap. Weeks is a long time to manage without a plan, and your team can put one in place if they know early enough.

Ordering from a registered online pharmacy that requires a valid prescription is legal in India and can be a practical option when local stock is unavailable. Before you do, confirm the supplier is registered with CDSCO and that the medicine name, strength, and manufacturer match exactly what your oncologist prescribed. Do not order from unverified sources — counterfeit cancer medicines carry serious risks. Ask your team whether they work with a preferred pharmacy network.

Call your team the same day. Oral targeted therapies and immunotherapy tablets often have specific dosing intervals that matter for how well the treatment works, and some are also dosed around food or other medicines in a precise way. Running out is not a reason to panic, but it is a reason to act immediately rather than wait for your next appointment. Your team may be able to arrange a bridge prescription or an emergency dispensing from the hospital pharmacy.

Hormone therapy for cancer works over months and years, so a gap of a few days is generally less immediately critical than a gap in chemotherapy or targeted therapy. That said, consistent daily dosing is what delivers the long-term benefit, and extended interruptions do matter. Contact your team so they can advise on your specific medicine and arrange a refill through another channel if needed. Do not assume it can wait until your next scheduled appointment.

Tell your team plainly. Cost is one of the most common reasons people quietly miss doses, and it is a solvable problem that becomes harder to solve the longer it goes unspoken. Many cancer medicines in India are available under government schemes including PM-JAY and state cancer welfare programmes, and oncology teams often know which pharmacies stock the most affordable versions. Silently stopping a cancer medicine because of cost causes real harm — the conversation does not.

Tell your doctor. Pharmacies resolve supply problems on their own timeline, which may not align with yours. Your oncologist needs to know when your treatment is at risk of interruption so they can decide whether the gap is clinically acceptable or whether action is needed. A quick message through the hospital helpline or WhatsApp number is enough — you do not need to wait for a formal appointment to flag this.